Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hunan Er-Kang Pharmaceutical Co Ltd

+ Add to Watchlist

300267:CH

42.290 CNY 1.790 4.42%

As of 02:00:30 ET on 03/03/2015.

Snapshot for Hunan Er-Kang Pharmaceutical Co Ltd (300267)

Open: 41.920 Day's Range: 41.800 - 43.910 Volume: 4,613,830
Previous Close: 40.500 52wk Range: 24.816 - 44.970 1-Yr Rtn: +53.90%

Stock Chart for 300267

No chart data available.
  • 300267:CH 42.290
  • 1D
  • 1M
  • 1Y
40.500
Interactive 300267 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 300267

Current P/E Ratio (ttm) 67.1270
Estimated P/E(12/2015) 49.7529
Relative P/E vs. SZ399006 0.8933
Earnings Per Share (CNY) (ttm) 0.6300
Est. EPS (CNY) (12/2015) 0.8500
Est. PEG Ratio -
Market Cap (M CNY) 19,219.96
Shares Outstanding (M) 454.48
30 Day Average Volume 2,218,479
Price/Book (mrq) 14.4865
Price/Sale (ttm) 14.0932
Dividend Indicated Gross Yield 0.24%
Cash Dividend (CNY) 0.1000
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 300267

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 300267

Hunan Er-kang Pharmaceutical Company Limited develops, produces and sells pharmaceutical products. The Company's main product include pharmaceutical excipients and antibiotic products.

Shuai FangwenChairman/PresidentWang XiangfengVice President
Liu AijunVice PresidentLuo LangVP/Secretary
More Company Profile & Key Executives for 300267

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil